Skip to content
★ Sign in to follow
MF

Markus F. Herzig

Allos Therapeutics Inc
Total declarations
4
Company
1
▲ Purchases (4 ops.)
€6,073
▼ Sales (0 ops.)
—

Latest filing published 03 Jan 2007 for ALLOS THERAPEUTICS INC, €1,669.

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Markus F. Herzig: trading record in brief

This profile gathers the share dealings of Markus F. Herzig in Allos Therapeutics Inc. Over a trading history stretching from 30 December 2005 to 29 December 2006, the count stands at 4 filings.

The open-market record is one-sided, with 4 purchases worth €6,073 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2007 alone, the filings show 1 purchase and no sales.

The median purchase comes to €1,753.

The record was last updated on 3 January 2007 with an open-market purchase (€1,669) in Allos Therapeutics Inc. Typically, a trade is published a median of 5 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Markus F. Herzig

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ▲
    VP Regulatory AffairsExecutivesAllos Therapeutics Inc
    2,202 USD0SEC
    1,210 shares@ US$1.82Common StockSEC:0001097264-07-000005:0
    Canonical exit: 29 Mar 2007 (T+90)
  • ▲
    VP Regulatory AffairsExecutivesAllos Therapeutics Inc
    2,348 USD0SEC
    1,290 shares@ US$1.82Common StockSEC:0001097264-06-000042:0
    Canonical exit: 28 Sept 2006 (T+90)
  • ▲
    VP Regulatory AffairsExecutivesAllos Therapeutics Inc
    573 USD0SEC
    250 shares@ US$2.29Common StockSEC:0001097264-06-000007:0
    Canonical exit: 17 Apr 2006 (T+90)
  • ▲
    VP Regulatory AffairsExecutivesAllos Therapeutics Inc
    2,481 USD0SEC
    1,363 shares@ US$1.82Common StockSEC:0001097264-06-000003:0
    Canonical exit: 30 Mar 2006 (T+90)

4 of 4 declarations